About Healthcare News
Novo CEO pressed by Senate to chop prices of being overweight, diabetes medicines CEO Lars Fruergaard Jørgensen told lawmakers the business would contemplate new talks with insurers concerning the list selling prices of Wegovy and copyright should they pledge to help keep the medicines on their own formularies.Elevance lowers direction on ‘unpar